ADMA Biologics, Inc. (ADMA)
9.615
+0.04
(+0.37%)
USD |
NASDAQ |
Sep 04, 16:00
9.52
-0.10
(-0.99%)
After-Hours: 19:16
ADMA Biologics Cash and Short Term Investments (Annual) : 87.63M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 87.63M |
| December 31, 2024 | 103.15M |
| December 31, 2023 | 51.35M |
| December 31, 2022 | 86.52M |
| December 31, 2021 | 51.09M |
| December 31, 2020 | 55.92M |
| December 31, 2019 | 26.75M |
| December 31, 2018 | 22.75M |
| Date | Value |
|---|---|
| December 31, 2017 | 44.61M |
| December 31, 2016 | 15.31M |
| December 31, 2015 | 16.81M |
| December 31, 2014 | 21.85M |
| December 31, 2013 | 29.08M |
| December 31, 2012 | 12.54M |
| December 31, 2011 | 0.0878M |
| December 31, 2010 | 0.229M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Erasca, Inc. | 276.08M |
| Krystal Biotech, Inc. | 827.79M |
| Vericel Corp. | 137.50M |
| Emergent BioSolutions, Inc. | 209.10M |
| Exelixis, Inc. | 1.059B |